Swedish pharmaceutical firm Astra has called in UK-based Complete
Pharma PR to develop an international communications programme for its
respiratory medicine subsidiary.
Astra Draco develops pharmaceuticals and drug delivery technology for a
range of respiratory diseases such as asthma, rhinitis and chronic
Products include asthma treatment Pulmicort, the Turbuhaler inhaler
system and Entocort for the treatment of bowel diseases.
CPPR’s appointment follows pitches from the firm’s previous agency
Interscience and Scope Ketchum earlier this year. The agency has been
briefed to draw up a blueprint PR campaign to be implemented in
individual country markets by Astra communications managers and local
public relations agencies.
Complete Pharma PR managing director Scott Clark said the programme
would seek to educate doctors, patients and their families about Astra
Draco’s products and ’cross-pollinate ideas’ among the company’s staff
through an internal communications programme.
In addition, Complete Pharma will work on EFAnet, the Internet site of
the European Federation of Asthma and Allergy Associations, which is
sponsored by Astra. Clark said the agency will be offering advice on the
design of the web site and its content.
Earlier this year another Astra subsidiary, Astra Pain Control, hired
CPPR to support its treatment for male impotence.